CD274 and renal cell carcinoma: Importantly, we have reported that Honokiol can also inhibit the expression of tumor cell PD-L1, the ligand for immune checkpoint molecule PD-1; and combination treatments with RTK inhibitors and immune checkpoint inhibitors (like anti-PD-1) are being tested in clinic for RCC [6, 53].